Myriad Genetics Inc (MYGN)

Financial leverage ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total assets	US$ in thousands	1,027,600	1,146,500	1,198,700	1,320,700	1,418,800
Total stockholders’ equity	US$ in thousands	701,100	783,200	885,800	967,800	881,000
Financial leverage ratio		1.47	1.46	1.35	1.36	1.61

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,027,600K ÷ $701,100K
= 1.47

The financial leverage ratio of Myriad Genetics Inc has shown a decreasing trend over the years, from 1.61 in December 2020 to 1.47 in December 2024. This indicates that the company has been gradually reducing its reliance on debt financing compared to its equity. Although there was a slight uptick in 2023, the overall trend suggests an improvement in the company's financial health and stability. A lower financial leverage ratio typically signifies a lower risk of financial distress and indicates a stronger financial position for the company. This trend suggests that Myriad Genetics Inc is managing its debt levels effectively and may be pursuing a more conservative financial strategy.